Literature DB >> 6922819

Complement activation and complement control proteins in acute pancreatitis.

J T Whicher, M P Barnes, A Brown, M J Cooper, R Read, G Walters, R C Williamson.   

Abstract

Serum levels of the complement proteins C3, C4, C1 inhibitor (C1 INH), factor I (C3b inactivator) and factor H (BIH) and plasma levels of cleavage products of C3 (C3c) and factor B were measured in 26 patients with acute pancreatitis. Breakdown of C3 occurred in 19 patients, as shown by a reduction in C3 level and the presence of C3c. C4 levels, however, did not fall and factor B breakdown products were not detected, thus suggesting that enzymatic cleavage of C3 occurred without significant involvement of either the early classical pathway or the alternative pathway. C1 INH and factor H both showed increases, presumably reflecting an acute phase response. Factor I showed an initial fall followed by a rise. There was no correlation between the presence or extent of C3 breakdown and the clinical condition of the patients. It is concluded that C3 cleavage in pancreatitis probably results from tryptic activity and that the measurement of complement components has no part to play in the management of the disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6922819      PMCID: PMC1419797          DOI: 10.1136/gut.23.11.944

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

Review 1.  The value of complement assays in clinical chemistry.

Authors:  J T Whicher
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

2.  Experimental pancreatitis in the dog. Demonstration of trypsin in ascitic fluid, lymph and plasma.

Authors:  K Ohlsson; H Tegner
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Experimental pancreatitis in the dog. Appearance of complexes between proteases and trypsin inhibitors in ascitic fluid, lymph, and plasma.

Authors:  K Ohlsson
Journal:  Scand J Gastroenterol       Date:  1971       Impact factor: 2.423

4.  Clinical applications of immunofixation: detection and quantitation of complement activation.

Authors:  J T Whicher; J Higginson; P G Riches; S Radford
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

5.  Changes in antigenic properties of human C3 upon activation and conversion by trypsin.

Authors:  J L Molenaar; M A Müller; C P Engelfriet; K W Pondman
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

6.  The serum complement system--a mediator of acute pancreatitis.

Authors:  R Seelig; V Ehemann; C Tschahargane; H P Seelig
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

7.  Complement system in sodium taurocholate pancreatitis in the rat.

Authors:  R Seelig; P G Lankisch; H Koop; K Winckler; U Kaboth; H P Seelig
Journal:  Res Exp Med (Berl)       Date:  1978-12-27

8.  Serum complement factors in human acute pancreatitis.

Authors:  P G Lankisch; H Koop; U Kaboth
Journal:  Hepatogastroenterology       Date:  1981-10

9.  A study of the breakdown of the third component of human complement (C3).

Authors:  M Fontaine; C Rivat
Journal:  Ann Immunol (Paris)       Date:  1979 May-Jun

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  12 in total

1.  Immunosuppression in patients with severe acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

Review 2.  Early assessment of severity in acute pancreatitis.

Authors:  R C Williamson
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

3.  P-selectin expression and Kupffer cell activation in rat acute pancreatitis.

Authors:  E Folch; N Prats; G Hotter; S López; E Gelpi; J Roselló-Catafau; D Closa
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

4.  Prediction of pancreatic necrosis by dynamic pancreatography.

Authors:  E L Bradley; F Murphy; C Ferguson
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

5.  Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats.

Authors:  C Largman; R D Reidelberger; H Tsukamoto
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

6.  Loperamide has antisecretory activity in the human jejunum in vivo.

Authors:  S Hughes; N B Higgs; L A Turnberg
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

7.  Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases.

Authors:  Javier Pereda; Luis Sabater; Norberto Cassinello; Luis Gómez-Cambronero; Daniel Closa; Emma Folch-Puy; Luis Aparisi; Julio Calvete; Miguel Cerdá; Salvador Lledó; José Viña; Juan Sastre
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

8.  Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.

Authors:  Roman Fischer; David C Trudgian; Cynthia Wright; Gethin Thomas; Linda A Bradbury; Matthew A Brown; Paul Bowness; Benedikt M Kessler
Journal:  Mol Cell Proteomics       Date:  2011-10-13       Impact factor: 5.911

Review 9.  Redox signaling in acute pancreatitis.

Authors:  Salvador Pérez; Javier Pereda; Luis Sabater; Juan Sastre
Journal:  Redox Biol       Date:  2015-01-28       Impact factor: 11.799

10.  The early predictive role of complement C3 and C4 in patients with acute pancreatitis.

Authors:  Lifeng Zhang; Zhenguo Qiao; Huang Feng; Jiaqing Shen
Journal:  J Clin Lab Anal       Date:  2020-03-18       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.